Contrast associated nephropathy after intravenous administration: what is the magnitude of the problem?

Renal Failure

Yanika Wolfe¹  Jean-Sebastien Rachoin¹  Sharad Patel¹  Elizabeth Cerceo² 

[1] Department of Critical Care Medicine, Cooper University Health Care;Division of Hospital Medicine, Cooper University Health Care;

关键词: acute kidney injury;    contrast-induced nephropathy;    ct scan;    outcomes;    incidence;    esrd;   

DOI  :  10.1080/0886022X.2021.1978490

来源: DOAJ

【 摘 要 】

Intravenous contrast media (CM) is often used in clinical practice to enhance CT scan imaging. For many years, contrast-induced nephropathy (CIN) was thought to be a common occurrence and to result in dire consequences. When treating patients with abnormal renal function, it is not unusual that clinicians postpone, cancel, or replace contrast-enhanced imaging with other, perhaps less informative tests. New studies however have challenged this paradigm and the true risk attributable to intravenous CM for the occurrence of CIN has become debatable. In this article, we review the latest relevant medical literature and aim to provide an evidence-based answer to questions surrounding the risk, outcomes, and potential mitigation strategies of CIN after intravenous CM administration.

【 授权许可】

Unknown